Current Diagnosis and Management of Cervical Spondylotic Myelopathy.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

Conflict of interest statement: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. 6. World Neurosurg. 2020 Aug;140:548-555. doi: 10.1016/j.wneu.2020.03.100. Cervical Spondylotic Myelopathy: When and Why the Cervical Corpectomy? Pescatori L(1), Tropeano MP(2), Visocchi M(3), Grasso G(4), Ciappetta P(5). Author information: (1)Department of Neurosurgery, Sant'Eugenio Hospital, Rome, Italy; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy. (2)Humanitas Clinical and Research Hospital & Department of Neurosciences, Humanitas University, Rozzano, Italy. Electronic address: mariapia.tropeano@libero.it. (3)Institute of Neurosurgery, Catholic University of Rome, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy. (4)Neurosurgical Unit, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy. (5)Department of Neurosurgery, University of Bari Medical School, Bari, Italy. BACKGROUND: Cervical spondylotic myelopathy (CSM) is a degenerative disease that represents the most common spinal cord disorder in adults. The best treatment option has remained controversial. We performed a prospective study to evaluate the clinical, radiographic, and neurophysiologic outcomes for anterior cervical corpectomy in the treatment of CSM. METHODS: From January 2011 to January 2017, 60 patients with CSM were prospectively enrolled in the present study. The patients were divided according to the modified Japanese Orthopaedic Association scale (mJOA) score into 2 groups: group A, patients with mild to moderate CSM (mJOA score ≥13); and group B, patients with severe myelopathy (mJOA score